20
Participants
Start Date
April 30, 2010
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
Xeomin
Patients will receive Xeomin only at Day 0.
Placebo / Xeomin
Patients will receive 0.9% mL NaCl alone at Day 0. After unblinding (at week 12) patients who were randomized to placebo will receive Xeomin.
Innovaderm Research Inc, Montreal
Lead Sponsor
Collaborators (1)
Merz Pharmaceuticals GmbH
INDUSTRY
Innovaderm Research Inc.
OTHER